Background: in patients with chronic kidney disease (CKD), the inflammatory and pro-
oxidant milieu may contribute to malnutrition development. In this study, we investigated the …

Patients with chronic kidney disease (CKD) are affected by enhanced oxidative stress and
chronic inflammation, and these factors may contribute to increase advanced glycation end …

Advanced glycation end-products (AGE) can promote chronic kidney disease (CKD)
progression and CKD-related morbidities. The soluble receptor for AGE (sRAGE) is a …

Background Advanced glycation end products and their cell-bound receptors are thought to
mediate the adverse effects of vascular disease through oxidative stress, inflammation and …

Background: Advanced glycation end products (AGEs) accumulate in patients with
decreased renal function and exert various toxic effects through the receptor for AGEs …

Background. The receptor for advanced glycation end products (RAGE) is involved in the
pathogenesis of vascular and inflammatory diseases. The pathological effects mediated via …

End‐stage renal disease patients on dialysis (CKD‐G5D) have a high mortality rate due to
cardiovascular diseases (CVD). In these patients, inflammation, oxidative stress, and uremia …

Patients with chronic kidney disease (CKD) are more prone to oxidative stress and chronic
inflammation, which may lead to an increase in the synthesis of advanced glycation end …

Abstract Background/Aims: The relationship of circulating endogenous secretory receptor for
advanced glycation end products (esRAGE) and chronic kidney disease (CKD) has not …

Interaction of advanced glycation end products (AGEs) with its cell-bound receptor (RAGE)
results in cell dysfunction through activation of nuclear factor kappa-B, increase in …